DeepInfra | $107,000,000 | (May 5, 2026)
Kibu, Inc | $10,500,000 | (May 5, 2026)
Fun | $72,000,000 | (May 5, 2026)
Athernal Bio
United Kingdom
- Cambridge
- 02/10/2025
- Unknown
- $4,718,630
Developing targeted immunotherapies to treat high-risk clonal haematopoiesis (CH)—the precursor to blood cancers—so we can stop cancer before it starts.
- Industry Biotechnology Research
- Website https://www.athernalbio.com/
- LinkedIn https://www.linkedin.com/company/athernal-bio/
Related People
Colin FreundFounder
United States -
New York City Metropolitan Area
C-level executive with experience in both private and public biotechnology companies, with 18 years' experience leading multinational teams that drive revenue generation and corporate value creation: company leadership (including venture fundraising); strategic planning, business/corporate development and M&A ($500M+ in multiple licensing/M&A transactions); corporate restructuring; alliance management; commercial development and product launch preparation; supply chain optimization; organizational development; investor relations/fundraising; and business interface on regulatory strategy in the USA, Europe and Asia.
Panthalassa | $140,000,000 | (May 5, 2026)
Featherless AI | $20,000,000 | (May 5, 2026)
Healthfab | $2,100,000 | (May 5, 2026)
LakeFusion | $7,500,000 | (May 5, 2026)
Enzo Health | $20,000,000 | (May 5, 2026)
Barocal | $10,000,000 | (May 5, 2026)
Zapdos Labs | $500,000 | (May 5, 2026)
Blomma | $5,000,000 | (May 1, 2026)
Dreambase | $3,700,000 | (May 1, 2026)